These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6369542)

  • 1. The "true speckled" antinuclear antibody (ANA) pattern: its tumultuous history.
    Burnham TK; Kleinsmith DM
    Semin Arthritis Rheum; 1983 Nov; 13(2):155-9. PubMed ID: 6369542
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and laboratory characteristics of patients with speckled pattern antinuclear antibodies.
    McMillan SA; Fay AC; Taggart AJ; McCrea JD; Roberts SD; Boyd MW; Nelson JK; Haire M
    Ulster Med J; 1986 Oct; 55(2):112-7. PubMed ID: 3492803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinuclear antibodies in Thai patients with connective tissue diseases.
    Panicheewa S; Verasertniyom O; Chitrabamrung S; Vanichapuntu M; Vatanasuk M
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):47-52. PubMed ID: 3304322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD; Turner RA
    Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N; Bosković B
    Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract]   [Full Text] [Related]  

  • 8. Antinuclear antibodies in systemic lupus erythematosus. Detection with horseradish-peroxidase-conjugated antibody.
    Benson MD; Cohen AS
    Ann Intern Med; 1970 Dec; 73(6):943-9. PubMed ID: 4947942
    [No Abstract]   [Full Text] [Related]  

  • 9. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue specificity of antinuclear antibodies in scleroderma.
    Błaszczyk M; Beutner EH; Rogoziński T; Rzesa G; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski TP
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):761-4. PubMed ID: 107922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of antinuclear antibodies in systemic rheumatic diseases.
    Hietarinta M; Lassila O
    Ann Med; 1996 Aug; 28(4):283-91. PubMed ID: 8862680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blastic lymphocyte transformation in lupus erythematosus and scleroderma].
    Pawińska M; Gliński W; Blaszczyk M; Wranicz A
    Przegl Dermatol; 1973; 60(2):161-6. PubMed ID: 4134109
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of the anti-Sm antibody].
    Chen DL
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):13-5. PubMed ID: 3109698
    [No Abstract]   [Full Text] [Related]  

  • 15. Two new antinuclear antibodies: their relationship to the homogeneous immunofluorescent pattern.
    Ritchie RF
    Arthritis Rheum; 1968 Feb; 11(1):37-43. PubMed ID: 4867854
    [No Abstract]   [Full Text] [Related]  

  • 16. Substrate specificity of antinuclear antibodies in scleroderma.
    Blaszczyk M; Beutner EH; Rogozinski T; Rzesa G; Jarzabek-Chorzelska M; Jablonska S; Chorzelski TP
    J Invest Dermatol; 1977 Apr; 68(4):191-3. PubMed ID: 66298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of antinuclear antibodies with special reference to the immunofluorescent speckled pattern].
    Anger RD
    Z Hautkr; 1986 Nov; 61(21):1515-23. PubMed ID: 2433842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients.
    Stojan B
    Ann Rheum Dis; 1975 Apr; 34(2):197-8. PubMed ID: 1094966
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of antinuclear antibodies (including LE test)].
    Tsunematsu T; Nakagawa J; Kusudo K
    Nihon Rinsho; 1976; 34 suppl():2619-31. PubMed ID: 62859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.